Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYZB | CRSP | GH | ||
| Company | Rayzebio Inc | Crispr Therapeutics Ag | Guardant Health Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 62.49 | 47.61 | 30.58 | ||
| High | 62.50 | 48.41 | 30.67 | ||
| Low | 62.48 | 46.30 | 29.26 | ||
| Last | 62.49 | 47.64 | 29.41 | ||
| Change | +0.01 | +0.79 | -0.80 | ||
| % Change | +0.02% | +1.69% | -2.65% | ||
| Volume | 282,700 | 1,593,508 | 657,065 | ||
| 20-Day Average Volume | 318,060 | 1,668,959 | 2,037,902 | ||
| Previous Close | 62.48 | 46.85 | 30.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 62.28 | 49.33 | 24.73 | ||
| 20-Day Raw Stochastic | 95.83% | 15.44% | 70.97% | ||
| 20-Day Relative Strength | 86.10% | 47.28% | 65.07% | ||
| Weighted Alpha | N/A | -30.88 | +28.64 | ||
| Today's Opinion | N/A | 80% Sell | 40% Buy | ||
| Previous Opinion | N/A | 80% Sell | 40% Buy | ||
| Last Month's Opinion | N/A | 64% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 02/15/24 | -7.89% since 11/08/24 | +3.88% since 11/08/24 | ||
| Low | 62.42 on 02/16/24 | 46.30 on 11/15/24 | 28.48 on 11/11/24 | ||
| High | 62.51 on 02/22/24 | 59.07 on 11/11/24 | 32.26 on 11/13/24 | ||
| 1-Month | |||||
| %Chg | +0.87% since 01/23/24 | -1.05% since 10/15/24 | +37.85% since 10/15/24 | ||
| Low | 61.86 on 01/24/24 | 45.44 on 10/23/24 | 20.14 on 10/25/24 | ||
| High | 62.51 on 02/22/24 | 59.07 on 11/11/24 | 33.64 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | +167.05% since 11/22/23 | -2.67% since 08/15/24 | +4.13% since 08/15/24 | ||
| Low | 22.14 on 11/27/23 | 43.42 on 09/06/24 | 20.14 on 10/25/24 | ||
| High | 62.51 on 02/22/24 | 59.07 on 11/11/24 | 33.64 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | N/A since 09/15/23 | -16.53% since 05/15/24 | +15.42% since 05/15/24 | ||
| Low | 17.95 on 09/26/23 | 43.42 on 09/06/24 | 20.14 on 10/25/24 | ||
| High | 62.51 on 02/22/24 | 67.88 on 06/13/24 | 37.04 on 07/30/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,744,400 | 3,998,788 | 3,732,597 | ||
| Shares Outstanding, K | 59,920 | 85,353 | 123,555 | ||
| Annual Sales | 0 | 371,210,000 | 563,950,000 | ||
| Annual Net Income | -68,600,000 | -153,610,000 | -479,450,000 | ||
| Last Quarter Sales | 0 | 600,000 | 191,480,000 | ||
| Last Quarter Net Income | -18,190,000 | -85,940,000 | -107,750,000 | ||
| 60-Month Beta | N/A | 1.67 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 11/13/23 | -1.01 on 11/05/24 | -0.45 on 11/06/24 | ||
| Latest Earnings Date | 03/04/24 | 11/04/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||